DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,580.00
+90.00 (1.64%)
At close: Oct 2, 2025

DongKoo Bio & Pharma Revenue

DongKoo Bio & Pharma had revenue of 60.12B KRW in the quarter ending June 30, 2025, a decrease of -1.94%. This brings the company's revenue in the last twelve months to 242.55B, up 0.90% year-over-year. In the year 2024, DongKoo Bio & Pharma had annual revenue of 249.27B with 15.57% growth.

Revenue (ttm)
242.55B
Revenue Growth
+0.90%
P/S Ratio
0.62
Revenue / Employee
600.38M
Employees
404
Market Cap
150.62B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024249.27B33.59B15.57%
Dec 31, 2023215.69B20.70B10.62%
Dec 31, 2022194.99B39.84B25.68%
Dec 31, 2021155.15B15.93B11.45%
Dec 31, 2020139.22B38.09B37.67%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition